Trials / Completed
CompletedNCT00414401
Clinical Reminders in Test Reports to Improve Guideline Compliance
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (estimated)
- Sponsor
- US Department of Veterans Affairs · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.
Detailed description
Background: Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal. Objectives: To determine if a reminder attached to the echocardiography report would increase the use of beta-blockers among patients with depressed left ventricular function. Methods: We are randomizing consecutive patients undergoing echocardiography at one of three VA echocardiography laboratories with reduced left ventricular ejection fraction (\<40%) and no echocardiographic contraindication to beta-blockers (e.g. aortic stenosis) to a reminder for use of beta-blockers or to no reminder. The reminder gives starting doses for two commonly used beta-blockers (carvedilol and metoprolol). Patients are excluded from the analysis if they leave the health care system or die within three months of randomization. The primary outcome is a prescription for a beta-blocker between three and nine months following echocardiography Status: The project is complete.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Clinical Reminder |
Timeline
- Start date
- 2001-05-01
- Completion
- 2006-06-01
- First posted
- 2006-12-21
- Last updated
- 2015-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00414401. Inclusion in this directory is not an endorsement.